Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

India’s Saptagir Partners With Jubilant On Remdesivir

As Dr Reddy’s Launches Its Version Through Gilead Partnership

Sep 17 2020

• By Akriti Seth

Remdesivir — 1712344666 • Source: Shutterstock

Related Content

Hikma Is Keeping On Top Of COVID ‘Rollercoaster’

Sep 09 2020

Gilead Licenses Remdesivir To Five Firms

May 13 2020

After Glenmark, Dr Reddy’s Launches Favipiravir For Indian Market

Aug 21 2020

Zydus Cadila Readies Injectables Push

Aug 14 2020

India Remdesivir Supply Gap May Normalize Soon, But No End To Greed

Jul 22 2020

How Cipla Is Aligning Manufacturing Amid The Pandemic

Aug 25 2020

Portuguese Plant Opens Up Prospects For Hikma To Expand In Europe

Aug 29 2019

Hetero Head On Remdesivir Partnering, Royalty Model

May 15 2020

Additional Topics

India Asia Pacific Coronavirus COVID-19 Manufacturing Strategy Deals BioPharmaceutical

More from Manufacturing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.